I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.

Leave site
Roche and Genentech at

Retina Society 2025

-
10:14 PM
Duration 4mins The Ritz-Carlton Chicago
Association of Early Macular Leakage Resolution With Extended Dosing Intervals in Patients With RVO: A BALATON/COMINO Post Hoc Analysis
Ivan Suñer, Bhatt HK, Danzig C, Dinah C, Dagincourt N, Pereira LP, Schweitzer J, Thommen J
06:45 PM
Duration 45mins Chicago, USA
Machine Learning–Based 3D Volumetric Analysis of Pigment Epithelial Detachment Reduction With Faricimab▼ vs Aflibercept in TENAYA/LUCERNE
Luis Acaba-Berrocal, Paolo Lanzetta, Yoshihiro Yonekawa, Thomas Albrecht, Emma Harrell, Derrek Hibar, Huanxiang Lu, Shriji Patel, Ming Yang, Philippe Margaron
03:55 PM
Duration 4mins The Ritz-Carlton Chicago
Comparative Efficacy of Faricimab▼ for the Treatment of Diabetic Macular Edema at 1 and 2 Years: A Systematic Literature Review and Network Meta-Analysis
Mark Barakat, Siedlecki J, Buehrer C, Cox O, Gibson K, Holekamp N, Mar F
04:03 PM
Duration 4mins The Ritz-Carlton Chicago
Quantitative Ultra-Widefield Fluorescein Angiography for the Assessment of Novel Biomarkers of Vascular Stability With Faricimab▼: A YOSEMITE/RHINE Post Hoc Analysis
Aleksandra Rachitskaya, Matar K, Indurkar A, Vecchia LD, Amine R, Mamone J, Tang A, Gibson K, Dagincourt N, Mar FA, Amador M, Warter A, Sim DA, Ehlers JP
04:07 PM
Duration 4mins The Ritz-Carlton Chicago
Reduced Hard Exudates and Microaneurysms With Faricimab▼ Compared With Aflibercept in YOSEMITE/RHINE Using Automated Segmentation of DME Lesions on Color Fundus Photography
Prethy Rao, Andreas Pollreisz, Sim D, Yang M, Benech AC, Gibson K, Benmansour F
04:11 PM
Duration 4mins The Ritz-Carlton Chicago
Treatment Response and Safety of Faricimab▼ in Underrepresented Patients With DME: Year 1 Results From ELEVATUM in the US
Matthew Cunningham, Amador M, Brown J, Coney J, Emanuelli A, Gonzalez L, Ha R, Huddleston S, Scott A, Milunovich S, Yang M, Lu X
04:19 PM
Duration 4mins The Ritz-Carlton Chicago
Impact of Continuous Ranibizumab Delivery via the PDS on Nonperfusion and Vascular Leakage in Eyes With Diabetic Retinopathy or Diabetic Macular Edema
Gill M, Couturier A, Balaratnasingam C, Emanuelli A, Suner I, Dakouras A, Latkany P, Plenty A, Gune S
04:23 PM
Duration 4mins The Ritz-Carlton Chicago
Retinal Fluid and Thickness Fluctuations in Patients With Diabetic Macular Edema: Impact of Continuous Delivery of Ranibizumab With the PDS From the Pagoda Trial Through Year 2
Marcus D, Eter N, Awh C, Hatz K, Tan G, Blotner S, Eghoej M, Gordon A, Heinrich D, Menezes A
07:19 PM
Duration 4mins The Ritz-Carlton Chicago
Four-Year Outcomes of Faricimab▼ in nAMD: Safety and Efficacy Results From the AVONELLE-X Long-Term Extension Trial
Arshad Khanani, Shriji Patel, Philippe Margaron, Marta S. Figueroa, Robyn Guymer, Timothy Y. Y. Lai, Andrew Lotery, Patricio Schlottmann, Veeral Sheth, Charles C. Wykoff, Ruobing Bai, Yannan Tang, Aachal Kotecha
07:23 PM
Duration 4mins The Ritz-Carlton Chicago
Greater Anatomical Improvements With Faricimab▼ vs Aflibercept 8 Weeks After Injections: A TENAYA/LUCERNE Post Hoc Analysis
Avni Finn, Varun Chaudhary, Nicholas Dagincourt, Shriji Patel, Philippe Margaron
07:31 PM
Duration 4mins The Ritz-Carlton Chicago
Baseline and Early Treatment Response Variables Associated With Faricimab▼ Durability in Treatment-Naïve nAMD: TENAYA/LUCERNE Post Hoc Analyses
Sambhara D, Bakall B, Koh A, Moshfeghi D, Souied E, Tan C, Vakharia P, Yang M, Patel S, Margaron P
07:36 PM
Duration 4mins The Ritz-Carlton Chicago
Five-Year Outcomes in PDS-Treated Patients With Neovascular Age-Related Macular Degeneration (nAMD) Enrolled in the Archway-to-Portal Trials
Awh C, Graff J, Kitchens J, Andrea-Thanei G, Blotner S, Gune S, Rabena M, Singh N
07:40 PM
Duration 4mins The Ritz-Carlton Chicago
Long-Term Efficacy and Safety of the First Patient Cohort Treated With the PDS for nAMD: Results from the Ladder and Portal Extension Trials, With Patient Follow-Up Through 7 Years
Mittra R, Khanani A, Awh C, Regillo C, Blotner S, Gune S, Heinrich D, Le Pogam S, Yaqub M
07:44 PM
Duration 4mins The Ritz-Carlton Chicago
Mitigating Conjunctival Erosions in Patients Treated With the PDS: Surgical Management and Clinical Outcomes
Klufas M, Suan E, Regillo C, Awh C, Gordon A, Blotner S, Prager A, Singh N, Utley S, Gune S
07:48 PM
Duration 4mins The Ritz-Carlton Chicago
Impact of Improvements to Surgical Procedure on the Incidence of Endophthalmitis and Associated Outcomes of Patients in the PDS Clinical Development Program
Carl Regillo, Margaret Chang, Nauman Chaudhry, Chui Ming Gemmy Cheung, Peter A. Campochiaro, Dante J. Pieramici, Shamika Gune, Philip Jaycock, David R. Kardatzke, Alisa J. Prager, Natasha Singh
07:57 PM
Duration 5mins The Ritz-Carlton Chicago
Faricimab▼ for Polypoidal Choroidal Vasculopathy: 1-Year Results From the Phase 3b/4 SALWEEN Trial
Junyeop Lee, Timothy Y. Y. Lai, Shih-Jen Chen, Tomohiro Iida, Adrian Koh, Won Ki Lee, Xiaorong Li, Paisan Ruamviboonsuk, Xiaodong Sun, Yasuo Yanagi, Ruobing Bai, Anh Nguyen Duc, Philippe Margaron, Gemmy Cheung
01:00 PM
Duration 4mins The Ritz-Carlton Chicago
Automated Quantification of Retinal Fluid Volume in Patients With Diabetic Macular Edema: Analysis of Faricimab▼ vs Aflibercept in YOSEMITE/RHINE
Colin Tan, Gibson K, Hibar D, Albrecht T, Lu H, Litts KM, Yang M, Holekamp N
01:04 PM
Duration 4mins The Ritz-Carlton Chicago
RHONE-X Extension Study: Clinical Improvements in Eyes With DME Switched From Aflibercept to Faricimab▼
Roger Goldberg, Pearce I, Sheth V, Khanani A, Jones C, Gibson K, Lai T, Schlottmann P, Sim D
01:26 PM
Duration 5mins The Ritz-Carlton Chicago
Real-World Steroid Utilization in Anti-VEGF-Treated DME From 2018 to 2023: A Retrospective Claims Analysis
Arevalo F, Ko S, Patel A, Bonine N, Amador M, Warter A, Medina C
01:46 PM
Duration 4mins The Ritz-Carlton Chicago
Predictors of Injection Numbers in Patients With Diabetic Macular Edema (DME) Treated With Faricimab▼ Personalized T&E in the Phase 3 YOSEMITE/RHINE Trials
Jesse Jung, Bianca Gerendas, Aude Ambresin, Fernando Arevalo, Manuel Amador, Kara Gibson, Dawn Sim, Alexandra Warter, Ming Yang
Coming soon